The primary goals of the Gynecologic Oncology Fellowship Program at Duke University Medical Center are to prepare trainees to deliver the best possible clinical care in the areas of diagnosis, treatment and prevention of gynecologic malignancies, and to provide a platform for trainees who aspire to careers in academics and research.
History of the Program
The Duke Gynecologic Oncology Fellowship was established in the early 1970s when formal programs were first created by the American Board of Obstetrics and Gynecology. The Division of Gynecologic Oncology and the fellowship program initially were founded and led by William T. Creasman, M.D. He played a pivotal role in the early endometrial cancer surgical staging studies performed by the GOG. In 1979, a year of laboratory research was incorporated into the Duke Gynecologic Oncology fellowship, and the first year research fellow does not have clinical responsibilities. Daniel L. Clarke-Pearson, M.D., became the Director of the Division of Gynecologic Oncology and the fellowship in 1986. He is a widely recognized researcher in the area of venous thrombosis. Under Dr. Clarke-Pearson’s leadership the faculty increased from two to five full-time gynecologic oncologists.
Our Director, Paula Lee, MD
Dr. Paula Lee has been a member of the Division of Gynecologic Oncology at Duke University Medical Center since 2007 after completing both residency and fellowship at Duke University Medical Center. She was appointed fellowship director in September 2016. Her research interests include therapeutic and surgical trials for gynecologic malignancies and improving end of life care. She is board certified in Hospice and Palliative Medicine. Her other interests include global health initiatives for middle and low resource countries to improve the care of women with gynecologic malignancies.